These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 17692293

  • 21. Childhood maltreatment, subsequent antisocial behavior, and the role of monoamine oxidase A genotype.
    Huizinga D, Haberstick BC, Smolen A, Menard S, Young SE, Corley RP, Stallings MC, Grotpeter J, Hewitt JK.
    Biol Psychiatry; 2006 Oct 01; 60(7):677-83. PubMed ID: 17008143
    [Abstract] [Full Text] [Related]

  • 22. Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys.
    Newman TK, Syagailo YV, Barr CS, Wendland JR, Champoux M, Graessle M, Suomi SJ, Higley JD, Lesch KP.
    Biol Psychiatry; 2005 Jan 15; 57(2):167-72. PubMed ID: 15652876
    [Abstract] [Full Text] [Related]

  • 23. Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors.
    Pinsonneault JK, Papp AC, Sadée W.
    Hum Mol Genet; 2006 Sep 01; 15(17):2636-49. PubMed ID: 16893905
    [Abstract] [Full Text] [Related]

  • 24. Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease.
    Yamagata H, Chen Y, Akatsu H, Kamino K, Ito J, Yokoyama S, Yamamoto T, Kosaka K, Miki T, Kondo I.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):320-3. PubMed ID: 15358178
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS, Heun R, Jessen F, Popp J, Hentschel F, Kelemen P, Schulz A, Maier W, Kölsch H.
    Neurobiol Aging; 2009 May 20; 30(5):691-6. PubMed ID: 17904251
    [Abstract] [Full Text] [Related]

  • 27. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F, Chiappelli M, Grimaldi LM, Morgan K, Kalsheker N, Calabrese E, Ritchie A, Porcellini E, Salani G, Franceschi M, Canal N.
    Neurobiol Aging; 2005 Apr 20; 26(4):449-53. PubMed ID: 15653173
    [Abstract] [Full Text] [Related]

  • 28. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences.
    Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ.
    Neuropsychopharmacology; 2004 Aug 20; 29(8):1498-505. PubMed ID: 15150530
    [Abstract] [Full Text] [Related]

  • 29. MAOA-VNTR Genotype Effects on Ventral Striatum-Hippocampus Network in Alzheimer's Disease: Analysis Using Structural Covariance Network and Correlation with Neurobehavior Performance.
    Chang HI, Chang YT, Tsai SJ, Huang CW, Hsu SW, Liu ME, Chang WN, Lien CY, Huang SH, Lee CC, Chang CC.
    Mol Neurobiol; 2019 Jun 20; 56(6):4518-4529. PubMed ID: 30338484
    [Abstract] [Full Text] [Related]

  • 30. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P, Afsharinejad Z, Kelada SN, Costa LG, Franklin GM, Swanson PD, Longstreth WT, Viernes HM, Farin FM, Smith-Weller T, Checkoway H.
    Mov Disord; 2004 Jan 20; 19(1):76-83. PubMed ID: 14743364
    [Abstract] [Full Text] [Related]

  • 31. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
    Maloney B, Ge YW, Alley GM, Lahiri DK.
    J Neurochem; 2007 Nov 20; 103(3):1237-57. PubMed ID: 17854398
    [Abstract] [Full Text] [Related]

  • 32. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease.
    Maes OC, Schipper HM, Chong G, Chertkow HM, Wang E.
    Neurobiol Aging; 2010 Jan 20; 31(1):34-45. PubMed ID: 18423940
    [Abstract] [Full Text] [Related]

  • 33. Maltreatment, MAOA, and delinquency: sex differences in gene-environment interaction in a large population-based cohort of adolescents.
    Aslund C, Nordquist N, Comasco E, Leppert J, Oreland L, Nilsson KW.
    Behav Genet; 2011 Mar 20; 41(2):262-72. PubMed ID: 20734127
    [Abstract] [Full Text] [Related]

  • 34. In vitro assays fail to predict in vivo effects of regulatory polymorphisms.
    Cirulli ET, Goldstein DB.
    Hum Mol Genet; 2007 Aug 15; 16(16):1931-9. PubMed ID: 17566082
    [Abstract] [Full Text] [Related]

  • 35. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
    Porcellini E, Calabrese E, Guerini F, Govoni M, Chiappelli M, Tumini E, Morgan K, Chappell S, Kalsheker N, Franceschi M, Licastro F.
    Neurosci Lett; 2007 Apr 06; 416(1):66-70. PubMed ID: 17284348
    [Abstract] [Full Text] [Related]

  • 36. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L, Li K, Zhang L, Yao S, Piao Z, Song L.
    Brain Res; 2009 Sep 29; 1291():133-9. PubMed ID: 19631630
    [Abstract] [Full Text] [Related]

  • 37. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC, Muñoz-Fernández C, Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J, Sánchez-García F.
    Neurosci Lett; 2007 Oct 29; 427(1):34-8. PubMed ID: 17923322
    [Abstract] [Full Text] [Related]

  • 38. No association between monoamine oxidase A promoter polymorphism and personality traits in Japanese females.
    Hakamata Y, Takahashi N, Ishihara R, Saito S, Ozaki N, Honjo S, Ono Y, Inada T.
    Neurosci Lett; 2005 Dec 09; 389(3):121-3. PubMed ID: 16139427
    [Abstract] [Full Text] [Related]

  • 39. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort.
    Tedde A, Putignano AL, Nacmias B, Bagnoli S, Cellini E, Sorbi S.
    Neurosci Lett; 2008 Dec 03; 446(2-3):139-42. PubMed ID: 18834925
    [Abstract] [Full Text] [Related]

  • 40. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder.
    Lim LC, Powell J, Sham P, Castle D, Hunt N, Murray R, Gill M.
    Am J Med Genet; 1995 Aug 14; 60(4):325-31. PubMed ID: 7485270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.